Average Co-Inventor Count = 7.84
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (26 from 2,405 patents)
2. Merck + Co., Inc. (3 from 4,770 patents)
3. Kilimanjaro Energy, Inc. (2 from 11 patents)
4. Carbon Sink, Inc. (1 from 11 patents)
32 patents:
1. 12454525 - IL4I1 inhibitors and methods of use
2. 12263171 - 7-, 8-, and 10-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use
3. 12060357 - 9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use
4. 12030872 - N-heteroaryl indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
5. 11312719 - 9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use
6. 11161854 - Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
7. 10945771 - Azabicyclo[4.1.0]heptane allosteric modulators of the M4 muscarinic acetylcholine receptor
8. 10556900 - TrkA kinase inhibitors, compositions and methods thereof
9. 10208060 - Inhibitors of HIF prolyl hydroxylase
10. 10065945 - Isoquinoline derivatives as MGAT2 inhibitors
11. 10000501 - Inhibitors of HIF prolyl hydroxylase
12. 9969752 - Inhibitors of HIF prolyl hydroxylase
13. 9914736 - TrKA kinase inhibitors, compositions and methods thereof
14. 9862716 - TRKA kinase inhibitors, compositions and methods thereof
15. 9815846 - TrkA kinase inhibitors, compositions and methods thereof